The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107 [1]

N. von Bubnoff; S. H.P. Gorantla; R. K. Kancha; F. Lordick; C. Peschel; Justus Duyster

doi:10.1038/sj.leu.2403887

The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107 [1]

N. von Bubnoff, S. H.P. Gorantla, R. K. Kancha, F. Lordick, C. Peschel, Justus Duyster^*

^*Corresponding author for this work

Department of Hematology and Oncology

Technical University of Munich

66 Citations (Scopus)

Original language	English
Journal	Leukemia
Volume	19
Issue number	9
Pages (from-to)	1670-1671
Number of pages	2
ISSN	0887-6924
DOIs	https://doi.org/10.1038/sj.leu.2403887
Publication status	Published - 09.2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/sj.leu.2403887

Cite this

@article{3361b0d08abd4ad8ad14455a97343f52,

title = "The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107 [1]",

author = "\{von Bubnoff\}, N. and Gorantla, \{S. H.P.\} and Kancha, \{R. K.\} and F. Lordick and C. Peschel and Justus Duyster",

year = "2005",

month = sep,

doi = "10.1038/sj.leu.2403887",

language = "English",

volume = "19",

pages = "1670--1671",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "9",

}

TY - JOUR

T1 - The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107 [1]

AU - von Bubnoff, N.

AU - Gorantla, S. H.P.

AU - Kancha, R. K.

AU - Lordick, F.

AU - Peschel, C.

AU - Duyster, Justus

PY - 2005/9

Y1 - 2005/9

UR - https://www.scopus.com/pages/publications/26944458584

U2 - 10.1038/sj.leu.2403887

DO - 10.1038/sj.leu.2403887

M3 - Letters

C2 - 16015383

AN - SCOPUS:26944458584

SN - 0887-6924

VL - 19

SP - 1670

EP - 1671

JO - Leukemia

JF - Leukemia

IS - 9

ER -

The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107 [1]

UN SDGs

Access to Document

Other files and links

Cite this